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Multivariate calibration of NIR spectroscopic sensors for 
continuous glucose monitoring 
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 We review different measurement strategies for continuous glucose monitoring 
 We elaborate the basic concepts of NIR spectroscopy for blood-glucose measurement 
 We critically review chemometrics tools for glucose measurement from NIR spectra  




Diabetes, a disorder in the control of blood-glucose levels, is one of the most serious metabolic 
diseases worldwide. Among the investigated technologies for continuous glucose monitoring 
(CGM), near-infrared spectroscopy (NIR) has received the most attention. There have been many 
attempts to develop NIR-based CGM systems with promising in-vitro results, but they lacked 
robustness for in-vivo use. We critically review the application of chemometrics for CGM and 
the research needed. Pre-processing and multivariate-calibration techniques, which allow 
exploiting expert knowledge on the potential interferences, are possible solutions. The 
combination and first overtone bands in the ranges 2050–2300 nm and 1500–1800 nm, 
respectively, are the most informative regions. We therefore recommended selecting the most 
informative variables and exploiting the available expert knowledge on known interferences in 














Abbreviations: (in standard style – alphabetical by abbreviation)  
NIR Near-infrared spectroscopy 
CGM Continuous glucose monitoring 
WHO World Health Organization 
FDA Food and Drug Administration 
DCCT Diabetes Care and Complications Trial 
MIR Mid-infrared 
SNR Signal-to-noise ratio 
MLR Multiple Linear Regression 
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PCA Principal Component Analysis 
PLSR Partial Least Squares Regression 
PCR Principal Component Regression 
ICA Independent Component Analysis 
ICR Independent Component Regression 
BSS Blind source separation 
DA Direct calibration 
CLS Classical Least Squares 
ACLS Augmented Classical Least Squares 
IDC Improved direct calibration  
SBC Science-based calibration 
NAS Net analyte signal 
RBFNN Radial Basis Function Neural Network 
SCMWPLS Searching Combination Moving Window Partial Least Squares 
GA Genetic Algorithm 
GS Grid Search 
LV Latent variable 
EMSC Extended multiplicative signal correction 
EISC Extended inverse scatter correction 
EPO External parameter orthogonalization 
GLSW Generalized least squares weighting 
OSC Orthogonal signal correction 
DF Digital filtering 
GSBDF Gaussian-shaped bandpass digital filters 
SEP Standard error of prediction  
RMSEC Root mean squared error of calibration 
RMSEP Root mean squared error of prediction 
RMSECV Root mean squared error of cross validation 
MSEP Mean squared error of prediction 
MSEC Mean squared error of calibration 
CV Cross validation 
MCCV Monte Carlo cross validation 
LOOCV Leave-one-out cross validation 
Lk-foldCV Leave-more-out cross validation 
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1. Introduction  
 
Diabetes, a disorder in the control of the blood-glucose level is considered to be one of the 
most serious metabolic diseases worldwide [1]. According to the World Health Organization 
(WHO) [2], about 60 million people or 10.3% of the male population and 9.6% of the female 
population in Europe suffer from diabetes. The situation is equally bad in the USA, where the 
Food and Drug Administration (FDA) reported that over 20 million people are affected [3]. The 
WHO estimates that around 3.4 million deaths are yearly caused by high blood-glucose levels 
[4]. Recently, it was predicted that the worldwide number of people with diabetes will increase 
from 246 million to 380 million by 2025 [5], while there still is no cure.  
Persistent high blood-glucose levels can cause serious health complications, such as heart 
diseases, blindness, kidney failure, nerve damage and impaired wound healing, which often leads 
to lower-extremity amputations [6]. The Diabetes Care and Complications Trial (DCCT) 
demonstrated that tight glycemic control delayed the onset of many of those complications and 
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that tight glycemic control was accomplished by frequent monitoring of blood glucose coupled 
with insulin therapy [7]. 
So far, the most successful way to control blood-glucose levels and delay onset of diabetic 
complications is through insulin therapy [8]. Proper use of insulin can prevent death from 
ketoacidosis in people with Type 1 or Type 2 diabetes and reduce complications due to chronic 
hyperglycemia in people with Type 2 diabetes [9]. The main purpose of insulin therapy is to 
prevent and to treat fasting and postprandial hyperglycemia [10], permit appropriate utilization 
of glucose and other nutrients by peripheral tissues [11] and suppress hepatic glucose production 
[12].However, in insulin therapy, it is crucial to find a balance between two life-threatening 
extremes:  
 when an insufficient dose of insulin is administered, the blood glucose cannot move from the 
blood into the cells, resulting in a high blood-glucose level (hyperglycemia) and burning of 
the fat and protein stores by the body, leading to the formation of ketone bodies (acetoacetate 
and β-hydroxybutyrate), which acidify the blood and cause metabolic acidosis; and,  
 if too high a dose of insulin is administered, the blood-glucose level becomes too low 
(hypoglycemia) and may cause unconsciousness or, in severe cases, brain damage and coma 
[10].   
 
2. Measurement strategies 
 
Three different strategies have been proposed to measure glucose in vivo: invasive, minimal 
invasive and non-invasive (Fig. 1). Invasive techniques use optical or electrochemical 
glucometers, minimal invasive techniques can be categorized into transdermal approaches, 
glucose electrodes, microdialysis and open-flow microperfusion, and, finally, non-invasive 
techniques are subdivided into optical and non-optical techniques.     
There are two invasive ways to measure blood glucose:  
 in capillary blood, through the use of a finger prick; and,  
 in venous blood, through the use of an indwelling vascular catheter [13].  
The drawback of venous/arterial vascular blood sampling is that it bears a small risk of 
infections and that a low skin temperature (18°C) can cause underestimation of the blood-
glucose concentration due to peripheral hypoperfusion, a condition where an organ or extremity 
does not receive sufficient blood [14,15].  
Minimally invasive methods (e.g., subcutaneous implants) measure the glucose concentration 
in the interstitial fluid of the skin or in the subcutis, for example, by using an electrochemical 
sensor [16,17]. These techniques rely on the correlation between the concentration of glucose in 
blood and interstitial fluid (ISF) and allow for repeated blood-glucose monitoring [18,19] during 
days of operation. On the down side, glucose biosensors suffer from rapid performance 
deterioration after implantation due to surface fouling and coagulation caused by poor 
biocompatibility [20]. There is therefore a need to develop more reliable techniques, which allow 
accurate measurement inside human bodies.  
Instead of using implantable sensors, it would be more desirable to monitor the glucose level 
continuously without pain and discomfort by not requiring piercing of the skin with a solid 
object to extract blood. A type of non-invasive CGM is based on non-optical techniques, which 
perform transdermal fluid extraction by compromising the epidermis with energy. Some 
techniques apply ultrasonic energy to the skin and measure the glucose concentration with a 
glucose-flux biosensor [21] or with electro-osmotic flow using reverse iontophoresis [22]. The 
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use of such devices for drug delivery or transdermal extraction of analytes of clinical interest is 
limited, due to their high cost and the risk of skin irritation [23,24]. 
Optical techniques, such as polarimetry [25], Raman spectroscopy [26], diffuse reflection 
spectroscopy [27,28], absorption spectroscopy [28, 29], thermal emission spectroscopy [30, 31], 
fluorescence spectroscopy
 
[32] and photoacoustic (PA) spectroscopy
 
[33,34], have been 
investigated to monitor levels of glucose in blood continuously in a non-invasive way. Several 
papers have reviewed different technologies in detail [35–37]. It was concluded by several 
authors that, although many attempts were made to measure glucose in biological tissues and 
some correlation exists between the measured optical signals and blood glucose, none could 
provide the proof that the measured signals correspond to the actual blood-glucose concentration 
[38]. Moreover, the development of a calibration model is challenging, because it must be robust 
enough to deal with light scattering caused by insoluble materials (e.g., fat and proteins) and to 
extract the often weak glucose signal from the complex biological matrix represented by the skin 
[36]. Tura et al. reviewed 14 optical technologies and 16 devices in detail according to 
quantitative criteria for glucose measurement [39].  
From all these optical techniques, most attention has been given to near-infrared (NIR) 
spectroscopy, because of its ability to record spectra for solid and liquid samples with no prior 
manipulation, the availability of portable equipment and the cost of the equipment. More 
importantly, NIR radiation can penetrate up to several millimeters into human tissue, serum and 
interstitial fluid [40,41]. Despite NIR spectroscopy being considered the most promising 
technique for CGM and being investigated by many research groups [35,37,38], it has not yet led 
to a commercial sensor, mainly because many instruments, which gave promising results in vitro, 
turned out not to be robust enough to measure glucose in vivo. 
 
2. Near-infrared spectroscopy 
 
2.1. Basic concepts of near-infrared spectroscopy 
 
The NIR region of the electromagnetic spectrum covers the wavelength range 750–2500 nm 
[42]. The absorption of NIR light in biofluids, such as blood or human serum, is mostly caused 
by the presence of C-H, O-H and N-H bonds, which can absorb photons with the right energy to 
excite overtone and combinations of fundamental molecular vibrations. The fundamental 
vibrations correspond to wavelengths in the mid-infrared (MIR). Glucose primarily absorbs NIR 
light in two distinct regions – the first overtone region at 1500–1800 nm and the combination-
band region at 2050–2300 nm. NIR spectroscopic measurement of glucose in aqueous solutions 
is quite challenging due to the low concentration of glucose compared to that of water, resulting 
in a far smaller signal for glucose compared to that of water. Moreover, variations in blood 
pressure, body temperature and some environmental factors, such as humidity, temperature and 
pressure, have an impact on the NIR spectra acquired and complicate their interpretation.  
 
2.2. Spectral basis for blood-glucose measurement 
 
To estimate the pure component spectra, a high-concentration solution of glucose (120 mM) 
was prepared and its NIR spectra were measured. The molar absorptivity of glucose was 
calculated following the procedure described by Amerov el al. [43]. The molar absorptivities of 
water and glucose in the first overtone band are presented in Fig. 2 (a) and (b), respectively. 
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Similarly, the molar absorptivities of water and glucose in the combination band are presented in 
Fig. 2 (c) and (d), respectively. Two important observations can be made from Fig. 2. First, it can 
be seen that the molar absorptivity of glucose is higher in the combination band than in the first 
overtone band. This implies that the signal of glucose in the combination band is higher than in 
the first overtone band. Whether this also results in a higher signal-to-noise ratio (SNR) depends 
on the presence of chemical interferents and instrumental characteristics, such as light intensity 
and detector noise. Second, comparisons of Fig. 2 (a) with Fig. 2 (b) and Fig. 2 (c) with Fig. 2 (d) 
reveal that the molar absorptivity of glucose is higher than that of water by a factor of 4–6. 
However, in blood serum or interstitial fluid, the aqueous glucose spectrum will be dominated by 
the characteristic water absorption, because the total number of glucose molecules for a given 
volume is much smaller. For the physiological concentration of 3.9–7.2 mM glucose, the ratio 
varies from 14,000 to 8000. 
Note that accurate calculations demand accounting for the impact of water displacement upon 
the dissolution of solute [43]. The phenomenon called water displacement is caused by the strong 
absorption of water throughout the NIR spectral region, leading to a significant change in 
absorbance spectra of dissolved solutes. In aqueous solutions, a specific molar volume of water 
is displaced by the solute molecules, resulting in fewer water molecules within the optical path of 
the spectroscopic measurement. Based on the relative magnitude of molar absorptivities of solute 
and water, negative absorbance values can be created, so the NIR spectra measured for aqueous 
solutions consist of both positive and negative absorbance regions.   
 
3. Chemometrics  
 
Due to the overlap between the absorption peaks of glucose and other molecules, there is no 
wavelength in the NIR spectrum that is only influenced by the glucose concentration, so the 
correlation of each individual wavelength variable with the glucose concentration is rather low 
and a univariate regression results in poor prediction of the glucose content. However, thanks to 
the broad absorption peaks in the first overtone and the combination bands, many wavelength 
variables are correlated to the glucose concentration. Moreover, the spectral signature of glucose 
is unique. These features make possible selective measurements of glucose by combining 
spectral information across a range of wavelengths. 
Multivariate calibration (MC) plays an important role in extracting quantitative information 
from multivariate analytical data, such as NIR spectra. Geladi and Kowalski described it in very 
simple words: “Multivariate calibration means measuring a vector of properties (variables) for 
calibration standards of known content. This vector may be spectral intensities, current 
measurements or any relevant collection of data” [44]. The most straightforward way to build a 
MC is by using Multiple Linear Regression (MLR), where the dependent variable is modeled as 
a linear combination of the independent variables and the regression coefficients are estimated 
with the least squares criterion [45-47]. An MLR model could be shown as follows:  
 
                                                                 (1) 
 
where y represents the estimated property (e.g., glucose concentrations), xi the wavelength 
variables, and bi the regression coefficients of the model. 
However, this modeling technique cannot be used when the number of variables is larger than 
the number of samples, because there is then no unique solution to the least squares estimation of 
Page 5 of 26
 6 
the regression coefficients, a problem known as “exact multicollinearity” [48]. Even when the 
number of samples is larger than the number of variables, MLR may lead to poor prediction 
performance when the different variables are highly correlated. In this case, an individual 
variable can be approximately written as a linear combination of other variables, leading to 
unreliable estimates for the regression coefficients. This problem is known as “near-
multicollinearity”. To overcome this problem, a biased regression can be used [49].   
Many approaches have been developed to overcome the (near) multicollinearity problem. 
Among all these approaches, Partial Least Squares Regression (PLSR) is by far the most widely 
used technique in analytical chemistry [50–52]. 
Since the goal of MC is to understand the relationship between variables and observations, the 
degrees of freedom are a function of both the sample size and the number of independent 
variables.  The degrees of freedom are equal to the number of samples minus the estimated 
number of parameters (e.g., slope). By increasing the sample size, the degrees of freedom also 
increase. By contrast, the degrees of freedom decrease by increasing the number of parameters. 
The number of degrees of freedom in a PCR model with k principal components (PCs) is k+1, 
due to the calculation of the mean spectrum for the mean-centering prior to the calculation of the 
PCs. So, to have sufficient power to estimate each of these degrees of freedom properly, it is 
recommended to use at least 6 times k+1 samples for building the model (ASTM E1655 - 
approved 2012 [53]). However, due to the definition of the latent variables (LVs) explaining 
maximal covariance between X and y, a PLS model can consume more than one degree of 
freedom per LV [54]. It is therefore recommended to build in some extra safety margin by using 
10 times k+1 samples for building the model. 
 
3.1. Partial Least Squares Regression 
 
PLSR [55] is used for describing a given response (dependent variable) as a function of a few 
LVs, which are called PLS factors. The LVs are derived from the original variables as linear 
combinations, which maximally capture the covariance between the independent variables (data 
matrix of absorbance values) and the dependent variables (vector of analyte concentrations). The 
PLS model is built using the following equation:  
 
                         X = TP
T
 + E                                              (2) 
 
                         y = Tq +e = Xb + e                                 (3) 
 
where X is the data matrix, q is the vector of regression coefficients associated with the PLS LVs 
(T), and matrix E and vector e are the residuals representing the differences between the 
observed and predicted X and the differences between the observed and predicted y, 
respectively. 
T is the score matrix for both X and y, P denotes the loading matrix. Scores are the projection 
of the samples onto the LVs. However, loadings are the projection of the LVs onto the original 
variables, which describe how the variables in the scores matrix T relate to the original data. X is 
the explanatory variables matrix and b is the vector of regression coefficients. It can be 
calculated as: 
  




q                                                             (4) 
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where W is a matrix of loadings maximizing the covariance criterion and P is the result of the 
projection of X onto the LVs. 
 
3.1.1. Model complexity 
A crucial aspect in building a biased regression model, like PCR and PLSR, is tuning the 
model complexity (i.e., the number of PCs for PCR or LVs for PLSR). As can be seen in Fig. 3, 
the bias for a built model decreases by increasing the model complexity (e.g., number of LVs), 
while the variance increases and vice versa [56,57]. The proper selection of PLS-model 
complexity (the best bias/variance trade-off) has always been questionable because, by selecting 
a few LVs, the model will produce bias in prediction, meaning that it leads to an under-fitted 
model. The opposite occurs by selecting too many LVs: the model built leads to overfitting with 
poor prediction ability due to spurious incorporated noise.  Bias relates to the prediction-
accuracy level of a model (e.g., how close the glucose-concentration values are to the predicted 
values). However, variance is the estimation error, which shows the level of uncertainty for the 
predicted values [58].  
Special attention should therefore be paid to this step in model building. Selection of a proper 
number of PLS LVs has been a subject of interest to chemometricians developing new 
techniques [59–71] or comparing existing techniques [72–76]. To assess the quality of a 
calibration model, standard statistical measures are normally applied. The standard error of 
prediction (SEP) is a measure of the variability of the difference between the predicted and 
actual values (precision) for a set of samples and does not take the systematic deviation (bias) 
into account [77]. Therefore, calibration models should not be evaluated only based on the SEP. 
It is suggested to use other metrics, such as the root mean squared error of prediction (RMSEP), 
which measures the accuracy (difference between predicted and actual values) and thus 
combines both the SEP (variance) and the bias in one term. Typically, the model complexity is 
tuned based on the minimization of the prediction error in the validation. The most used 
techniques are based on cross validation (CV) [76], Monte Carlo CV (MCCV) [60–64], 
randomization [65,66] and bootstrapping [67-71].  
Other metrics that include bias and variance information have been evaluated and discussed 
[54,79]. For example, Kalivas et al. [80] suggested using a variance indicator, such as the 
Euclidean norm (2-norm) of the regression coefficient vector ||b||
2
 by plotting it against a bias 
metric. However, the RMSECV (root mean squared error of cross validation) is typically used to 
select the optimal number of LVs [78].  
As mentioned above, CV techniques have been extensively used for tuning model complexity. 
One of the most popular CV techniques is Leave-One-Out CV(LOOCV). The idea behind an 
LOOCV method is to leave one sample out of a data set and use it for validation after building a 
model with remaining samples. This procedure is repeated in a way that each sample in the data 
set is used once as the validation data [81]. For larger sample numbers (> 20), there is a large risk 
that a sample very similar to the validation sample is also present in the calibration set. In this 
case, LOOCV will lead to the inclusion of unnecessary LVs, resulting in a better performance in 
CV, but a worse prediction ability of new samples (an over-fitted model). An Lk-foldCV would 
be a better choice for larger sample sets [82, 83]. It should be mentioned that LOOCV and k-fold 
CV or Lk-foldCV are conceptually the same, the only difference being that, in LOOCV, one 
sample is left out each time, while, in k-foldCV, several samples are left out. 
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It should be noted here that inverse modeling techniques, such as Principal Component 
Regression (PCR) and PLSR, are very sensitive to unspecific correlation between the spectral 
measurements and dependent variables present in the calibration data set. Such unspecific 
correlations can be caused by measurement artifacts that will not be persistent in the future. In 
order to safeguard against these, one should keep all related samples (e.g., measured on same day 
or for the same person) together in the calibration set or CV set [84].  
 
3.1.2. Partial Least Squares Regression for glucose measurement from NIR spectra 
Similar to other fields in analytical chemistry, PLSR has been the most frequently used 
inverse calibration method for predicting glucose concentration from spectroscopic signals. In a 
review paper, Arnold et al. [40] criticized the feasibility and the potential of non-invasive 
glucose monitoring for clinical blood-glucose measurements and bioreactor monitoring, because 
none of the existing patents published before 1996 provided a clear path or method for 
measuring glucose in vivo accurately. They concluded that, although some research groups had 
tried to measure glucose [85,86], none could prove that what was measured related to the glucose 
concentration, because subtle variations in spectra caused by, e.g., time or temperature might be 
correlated with glucose concentration. In these papers [85,86], the glucose level varied with time 
as spectra were collected, so the models built might have been based on this unspecific 
correlation.  
Table 1 gives an overview of the data sets and the aims of different studies that have been 
devoted to glucose measurement from NIR spectra. As can be seen, the group led by Arnold has 
devoted special attention to this field. At first, they measured glucose in the physiological range 
(1–20 mM) in an aqueous matrix [87]. With a univariate calibration linking the absorbance at 
2273 nm to the glucose concentrations, they obtained a prediction error of 0.3 mM on an external 
test set.  
Several groups have investigated the effect of temperature variation on the accuracy of 
glucose measurement in an aqueous solution. In one paper [88], a PLS model was trained on 
spectra acquired at 37°C and tested on spectra measured at temperatures of 32–41°C at 1°C 
increments. By pre-processing the spectra with a digital Fourier filter method, the effect of 
temperature variation on glucose predictions could be minimized and an SEP of 0.14 mM (2.52 
mg/dL) was obtained.  
In another study, the NIR spectra of nine samples were measured at different temperatures 
(25°C, 30°C and 35°C) [89]. Three of those samples were used to build a PLS model and the 
remaining samples were used as the test set. When no preprocessing was applied before building 
the model, the first loadings vector obtained from the PLS model corresponded to the observed 
absorbance change caused by the temperature variation. This demonstrates that the PLS model 
incorporated the effect of temperature variation in the model. However, the data set used was 
rather small with a lack of sample to sample variation and no experimental design was used.   
Other researchers have investigated the robustness of the glucose measurement from NIR 
spectra for other interferences, such as total protein concentration and glycated protein 
concentration [90,91]. To investigate the effect of the presence of protein on the glucose 
measurement, 97 spectra were collected from 14 glucose solutions over four days with glucose 
concentrations of 1.2–20.0 mM [92]. The protein concentration was 60.8 g/dl and constant for all 
solutions. The training and test set consisted of 67 and 34 spectra, respectively. The best PLS 
model using 14 LVs resulted in an SEP of 0.24 mM.  
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In another study, three different bovine plasma lots were used to prepare 69 glucose samples, 
55 samples and 14 samples as training and test sets, respectively [93].  The best PLSR model 
resulted in an SEP of 0.37 mM.   
To demonstrate the possibility of glucose measurement in samples with matrix variation, a 
series of binary mixture solutions of glucose and glutamine was prepared [94]. The concentration 
range of glucose and glutamine was 1.7–59.9 mM and 1.1–30.65 mM, respectively. A PLS 
model was built for each compound separately, resulting in SEPs of 0.32 mM and 0.75 mM for 
glucose and glutamine, respectively.  
To increase the complexity of the matrix, mixtures of glucose, glutamine, glutamate, lactate 
and ammonia-nitrogen were prepared [95]. The NIR spectra of the corresponding 72 aqueous 
solutions were randomly split into a training set of 58 samples for PLSR model building and a 
test set of 14 samples for model validation. A PLSR model was built based on 12 LVs, which 
resulted in an SEP of 0.53 mM.  
As the proteins and triglycerides present in serum-like solutions strongly overlap with the 
important absorption band of glucose around 2273 nm [96–98], it was investigated whether 
glucose can be measured in the presence of these molecules [99]. The PLS models resulted in 
SEPs of 0.5 mM and 0.2 mM in triacetin and bovine-serum albumin solutions, respectively.  
As a continuous glucose sensor should be able to measure the glucose level in blood or serum, 
several studies have investigated the potential to measure glucose in human serum using NIR 
spectroscopy. A set of 242 undiluted human-serum samples was randomly split into 162, 40 and 
40 samples as training, monitoring and test sets, respectively [100]. The monitoring set was used 
to optimize the calibration and the test set was used as a blind set to evaluate the prediction 
ability of the model built. The optimum PLS model using 14 LVs resulted in a 0.35 mM SEP. 
Another set of 50 serum samples, which had been measured before, were also used as a blind test 
set, resulting in an SEP of 2.91 mM. This indicates that the built model was not robust enough to 
handle the variation in different test sets, so the question of how to make a PLS model robust 
was highlighted by this study.  
Afterwards, a comparison was made between the application of NIR and Raman in glucose 
monitoring [101]. Some 60 aqueous solutions consisting of glucose, lactate, and urea were 
measured with NIR and Raman spectroscopy. The acquired spectra were then used for PLS-
model building. The data set was randomly split into 50 samples and 10 samples for training and 
test sets, respectively. The prediction ability of models built on NIR was better than for those 
built on the Raman data set. The SEP values obtained with PLS on the NIR data were 0.24 mM, 
0.11 mM and 0.14 mM for glucose, lactate and urea, respectively, while they were 0.40 mM, 
0.42 mM and 0.36 mM for the PLS models built on the Raman spectra.  
It should be noted that some studies were based on simulated data [102–104]. However, the 
results obtained for the models built in these studies were limited to those simulated data so we 
do not discuss them in this review. 
 
3.2. Alternative calibration methods for glucose measurement from NIR spectra 
 
In the previous section, we concluded that, although PLSR is able to capture both specific and 
unspecific covariance between the acquired spectral signals and the glucose content, it may result 
in MC models that are not robust enough for practical use, so other MC strategies were proposed.   
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3.2.1. Independent Component Analysis  
Independent Component Analysis (ICA), also known as Blind Source Separation (BSS) [105], 
aims to find the independent sources contributing to a mixed signal (e.g., an NIR spectrum). This 
is done by assuming that the data variables are linear mixtures of some unknown LVs. The LVs 
are assumed to be non-Gaussian and mutually independent, and are called the independent 
components of the observed data [106]. Linear ICA can be presented as [Equation (5)]:  
 
                                 X = AS+E                                                             (5) 
 
where  X  is an m×n matrix of m measured mixture spectra (absorbance values in the case of the 
Beer-Lambert law) for the p variables (e.g., wavelengths) and the n samples, A is an m×k mixing 
matrix, S is a k×n matrix of k independent components, and E is the matrix of residual spectra. 
This technique has also been evaluated for glucose measurement [107]. Some 90 NIR spectra 
were collected for 30 mixtures of a matrix prepared by dissolving glucose, urea and triacetin in a 
phosphate-buffer solution. The model was trained on 20 samples and tested on 10 different 
samples. The data matrix was decomposed into Scores, Loadings and Eigenvalues using PCA. 
The Scores matrix was then used as an input for ICA. The estimated mixing and independent 
components were obtained by ICA, and relative concentration levels of each component (A) in 
the mixtures were used to build an MLR model. Independent Component Regression (ICR) was 
built by using the selected number of scores from the PCA model as the input to ICA algorithm. 
The numbers of factors for ICR, PCA-ICR and PLS were 16, 18 and 13, respectively. PCA-ICR 
outperformed PLS and ICR with an SEP of 1.34 mM compared to 1.97 mM and 1.61 mM for 
PLS and ICR, respectively.  
 
3.2.2. Direct calibration methods 
The added value of expert knowledge in improving the robustness of MC models for glucose 
prediction was demonstrated [108]. Although Classical Least Squares (CLS) has been reported to 
be a useful technique for extracting qualitative information [109], it is rather limited when, e.g., 
the concentration of one or more compounds in a mixture is unknown. The CLS model is 
mathematically written as [Equation [6)]: 
 
                                                  X = CK+E                                             (6)  
  
where  X  is the m×n matrix of m measured mixture spectra (as described above), C is the m×p 
matrix of concentration values for the p components, K is the p×n matrix of the pure component 
signals (e.g., spectra) at unit concentration, and E is the matrix of residual spectra.  
To overcome this limitation of CLS, it has been proposed to estimate the contributions of the 
unknown components and augment the CLS equation. This method is known as augmented 
Classical Least Squares (ACLS) [110], which is done by augmenting the concentration matrix 
during the CLS calibration procedure [111] or augmenting the pure component spectral signal 
matrix [112,113]. The unknown components to be added in the augmentation can be estimated 
from the calibration set at hand [112,113], from a noise matrix (PACLS and IDC) [111], or 
directly measured for known interferents for which the concentrations are unknown
 
[114]. After 
augmentation of the pure component matrix, the spectral measurements are corrected from the 
interferences and then projected onto the pure component spectrum in order to obtain the 
coefficient vector, which can then be used further to predict an unknown sample [115].  
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Science-based calibration (SBC) is another direct calibration method inspired by a modular 
method in signal processing, known as Wiener filtering. It aims to isolate the analyte signal from 
the spectral noise without using costly reference values. The regression-coefficient vector is 
calculated by weighting the pure component spectrum of the analyte of interest with an estimate 
for the noise-covariance matrix
 
[116,117]. However, the net analyte signal (NAS) is the part of 
the pure component spectrum that is orthogonal to the interferents. Projecting X to Y in an 
attempt to remove the spectral information in X, which is orthogonal to y, is a method known as 
net analyte preprocessing (NAP).  
The prediction performance and robustness of NAP, IDC, SBC and ACLS using different 
amounts of expert knowledge have been evaluated and benchmarked against conventional PLS 
[108]. It was reported that the inclusion of expert knowledge in these alternative calibration 
techniques was found to reduce the dramatic effects of a change in the interferent structure on the 
prediction performance, even when the interferent structures in the test and training sets were 
different from each other. The ACLS model led to the best result when the pure component 
spectra of the analyte of interest and the interferents were incorporated. Hereby, the RMSEP was 
reduced by a factor 3 compared to conventional PLS when the test set had a different interferent 
structure than the calibration set for a similar range of glucose concentrations. 
 
3.2.3. Non-linear regression methods 
Light scattering and molecular interactions can cause (non-linear) deviations from the linear 
additive relation between the analyte concentrations and the acquired absorbance signals. In such 
cases, methods relying on the Beer-Lambert law may no longer be appropriate and non-linear 
calibration methods may be needed. The Radial Basis Function Neural Network (RBFNN) is a 
standard feed-forward neural network including three layers: an input layer, a Gaussian (RBF) 
function hidden layer and an output layer. The input layer consists of, e.g., NIR spectra, while 
the output layer contains the corresponding concentration values. The goal of an RBF network is 
to generate proper weights and biases connected between the input and the hidden layers, and 
between the hidden layers and the output target. This results in an output that is a linear 
combination of RBFs of the inputs and hidden layers [118]. More details are available [119,120].  
Fischbacher et al. compared the performance of RBFNN with PLSR in predicting the blood-
glucose level from 150 diffuse reflectance spectra in the 850–1300-nm range obtained through 
the fingers of three Type-1 people with diabetes [121]. The number of hidden neurons, which 
affects the performance of the RBFNN, was optimized by LOOCV. RBFNN outperformed PLS 
regression with RMSEP values of 1.4 mM and 1.9 mM, respectively. Although the non-linear 
technique led to a considerable improvement in prediction, it was a rather complex modeling 
technique and more difficult to tune. Note that the 1.4 mM and 1.9 mM values probably 
represent measurements based on changes in refractive index or spurious correlations; however, 
it is unlikely that the information in these calibration models originated from the spectrum of 
glucose due to the lack of glucose information in this spectral range. 
 
3.3. Variable selection  
 
Normally, data sets acquired with analytical instruments, such as NIR spectroscopy, contain 
many irrelevant features. By removing those irrelevant features, the prediction performance and 
robustness of the calibration models can be improved, so reducing the dimension of a 
multivariate data set is one of the most important steps in data handling. Variable-selection and 
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reduction techniques are used to simplify the interpretation of models with few variables, to 
improve the prediction performance, and to decrease the risk of overfitting and overtraining 
[122].  
In order to investigate the most informative part of the NIR spectra for glucose measurement, 
a variable-selection technique [e.g., Genetic Algorithm (GA)] was used or the spectra were 
manually split into several wavelength ranges and different models were built. In the latter case, 
the region that led to a better performance model was chosen to be the most informative region. 
Table 1 summarizes the aims of different reported studies, which mostly followed the latter 
strategy, e.g. [92], seven different spectral regions were examined based on three different 
glucose bands around 2128 nm, 2273 nm and 2325 nm. It was found that the most informative 
wavelength range was 2174–2326 nm, while the prediction ability of the PLS model decreases 
using the full spectrum. The same conclusions were drawn from glucose measurements under 
changing temperatures [99] and in undiluted plasma matrices [92]. The C-H combination band at 
2273 nm has proved to be the most useful band for building glucose-calibration models 
[44,88,92,93,123]. 
Searching Combination Moving Window Partial Least Squares (SCMWPLS) is a wavelength-
selection technique that searches the most relevant set based on a combination of informative 
regions or an optimized individual informative region. This strategy is quite simple and very 
similar to a forward selection started by setting a window size at the i
th
 spectral channel and 
ending at the (i
th 
+ window size-1). SCMWPLS has been evaluated to quantify glucose in vitro 
(bovine-serum samples) and in vivo (human-skin samples) [124]. The 1280–1849 nm range was 
selected for the 45 bovine-serum samples and the 1212–1889 nm range was selected for the 48 
human-skin samples. The optimized informative region for the in-vitro data set was found to be 
the combination of four informative regions of 1373–1429 nm, 1495–1545 nm, 1565–1696 nm 
and 1790–1805 nm, while, for the in-vivo data set, only one optimized informative region of 
1616–1733 nm was recognized. The best model for the in-vitro data set led to an RMSECV of 
1.40 mM and a correlation coefficient of 0.99 for eight PLS factors, while the best model for the 
in-vivo data set used the 1616–1733 nm region and resulted in a correlation coefficient of 0.92, 
an RMSECV of 0.95 mM and four LVs. It should be noted that these are CV results of segments, 
which might be overoptimistic, as the model complexity was selected to minimize the CV error, 
so  these results should still be validated on an independent test set. 
GAs are a well-known technique inspired by the concepts underlying evolution [125] to 
optimize the position and the width of the bandpass digital filter, wavelength and LV selections 
[126]. Shaffer et al. applied this technique to two sets of data:  
 the first was glucose in a phosphate-buffer matrix, including bovine serum albumin and 
triacetin (GTB); and,  
 the second was glucose in a human-serum matrix (serum).  
The prediction ability of models built based on three different fitness functions used in a GA 
process was investigated. The fitness functions used were based on the combination of Mean 
Squared Error of Calibration (MSEC) or Mean Squared Error of Prediction (MSEP) with the 
number of LVs, or a combination of both MSEC and MSEP with the number of LVs together. 
GA was compared to Grid Search (GS). The SEP for the GS-coupled PLS model using the GTB 
data set (spectral range 2242–2321 nm) and serum data set (spectral range 2062–2353 nm) were 
0.91 mM and 1.20 mM, respectively. However, the SEP for the GA-coupled PLS model using 
the GTB data set (spectral range 2174–2328 nm) and serum data set (spectral range 2085–2325 
nm) were 0.66 mM and 1.18 mM, respectively.   
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In another study, the same authors used three data sets. The first one was glucose free and the 
two others (GTB and serum data sets) were taken from on paper [127]. The SEPs of the PLS 
models, built on the 2000–2500 nm range (519 spectral points) for GTB and serum data sets, 
were 8.60 mM and 8.96 mM, respectively. Afterwards, they used GA to select the best region 
from 2000–2500 nm for both data sets. It was found that GA selected 153 and 230 spectral points 
for GTB and serum data, which were in the range 2081–2381 nm. The SEPs for GA-PLS for 
GTB and serum data sets were 0.64 mM and 1.13 mM, respectively. They concluded that the 
ranges of 2128–2326 nm and 2000–2083 nm included noise. In order to prove this, they built a 
PLS model for both data sets using the 2081-2381 nm wavelength range (312 spectral points). 
The SEP of PLS models for GTB and serum were 0.59 mM and 1.39 mM, respectively. Based 
on their observation, it was concluded that the glucose bands were located in the 2083–2381-nm 
range, while the ranges of 2128–2326 nm and 2000–2083 nm included noise.   
However, a GS was also applied on the same data set and resulted in selection of spectral 
ranges of 2119–2328 nm and 2061–2353 nm for data sets of GTB and serum, respectively. The 
SEP for GS-PLS for GTB and serum data sets were 0.66 mM and 1.36 mM, respectively. It was 
therefore concluded that GA was superior to not only GS, but also the built PLS models without 
performing any variable selection [127].  In another study [128], the same data set [126,127] was 
used and the same conclusion was drawn.  
Several research groups [129–132] investigated the question as to whether the first overtone 
band (1500–1800nm) or the combination band (2050–2300 nm) is the most informative. A 
comparison was made between PLS models built using the first overtone band and the 
combination band to measure glucose, lactate, urea, ascorbate, triacetin, and alanine in aqueous 
solutions [129]. Sample thicknesses, which affected the spectral quality, were 7.5 mm and 1.5 
mm for the first overtone and combination bands, respectively. Some 80 samples were split into 
training, monitoring and external test sets, consisting of 50, 15 and 15 samples, respectively. The 
PLS models for glucose resulted in SEPs of 1.12 mM and 0.45 mM for the first overtone and 
combination-band spectra, respectively.  
In another study, the first overtone and combination bands were compared for analyte 
measurements in aqueous solutions consisting of glucose, lactate, urea, ascorbate, triacetin and 
alanine [130–132]. In one paper [130], the best region was mentioned to be 2036–2324 nm, 
while it was reported [131] that a combination of the regions  (1473–1831 nm and 2111–2374 
nm) provided the best glucose-prediction accuracy.  
Furthermore, a grid search was used to find the optimal spectral range [132]. PLS models 
were built over the combination, first-overtone and short-wavelength spectral regions using 80 
different samples prepared from a single whole-blood matrix [132]. The SEP values obtained 
were 0.96 mM, 1.20 mM and 2.53 mM for combination band, first-overtone band and short-
wavelength regions, respectively. The authors tried 5100 combinations of spectral ranges, using 
model complexities of 1–15 LVs. The best spectral range within the combination band (2000–
2500 nm) was 2062–2381 nm. This spectral range consists of several known glucose-absorption 
features, centered at 2123 nm, 2272 nm and 2325 nm, which were used by the PLS models [87]. 
The best spectral range in the first-overtone and short-wavelength spectral region (1111–1852 
nm) was found through the grid search to be 1550–1754 nm. This selected region is situated in 
the first-overtone band and corresponds to several known glucose-absorption features centered at 
1613 nm, 1689 nm and 1731 nm [133]. The authors concluded that the exclusion of the short-
wavelength range from the optimized range is because this region is dominated by scattering. 
Moreover, this region lacks glucose-specific absorption features.  





Irrelevant variation in the acquired spectra due to measurement noise and background 
interferences can obscure the information on chemical variations in the analyte and increase the 
complexity of an MC model [57,134–136]. Different preprocessing techniques have therefore 
been proposed to remove the irrelevant variations and the background interferences from NIR 
spectra. A preprocessing technique does not necessarily improve the prediction ability, but can 
result in more parsimonious models that are expected to be more robust, thanks to the removal of 
unwanted variation (e.g., instrumental artifacts).  
Preprocessing techniques are normally used to adjust the variability of a measured variable 
(e.g., normalization or scaling) or to deal with typical artifacts for a given type of data (e.g., 
baseline correction). As discussed in a critical review on the selection of preprocessing 
techniques before data analysis [135], a complete pre-processing strategy for a given NIR data 
consists of the following steps:  
(1) baseline correction;  
(2) scatter correction; 
(3) noise removal; and.  
(4) scaling.  
In this review, we categorize the pre-processing methods into four classes (with details in the 
Supplementary material):  
(1) spectroscopic transformations; 
(2) scatter and baseline correction; 
(3) interference removal; and,  
(4) variable weighting.  
The use of prior information in preprocessing techniques (EMSC, EISC, EPO and GLSW) 
was demonstrated to improve the robustness of the PLS for modeling glucose [137]. This study 
was carried out on two data sets: 
 NIR spectra of aqueous solutions containing glucose, D-lactate and urea; and,  
 NIR spectra of powder mixtures containing glucose, lactate and casein.  
In the aqueous solution data set, a representative training set was provided for the calibration. 
In this case, it was demonstrated that the use of prior information could result into more accurate 
models, as discussed in many other cases [139,140].  
In the powder-mixture data set, the training and test sets were designed to have different 
interferent structures. As expected, the conventional PLS model was unable to cope with the 
change in interferent structure in the test set. In this case, the use of prior information in the 
model calibration step or in the preprocessing step resulted in a considerable reduction of the 
prediction error. It was concluded from this study that some preprocessing techniques, which use 
expert knowledge, successfully reduce the sensitivity of the resulting models to changes in the 
interferent structure. Among the preprocessing techniques using expert information, Spectral 
Interference Subtraction (SIS) was found to be an effective technique for both data sets used. 
Moreover, EPO, GLSW and EMSC were effective for only one data set. 
The key advantage of using these techniques is that they relax the requirement for a 
“representative” calibration set, so they open up perspectives for more efficient, economical MC 
model building. The approach adopted by the authors is especially interesting for glucose 
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measurements in biological fluids, such as human serum or interstitial fluid, where it is nearly 
impossible to obtain a “representative” calibration set for training the multivariate model. 
Of all orthogonal projection techniques, most attention has been given to the orthogonal 
signal correction (OSC) method, which was developed to remove systematic variation in the 
spectra that are not correlated to the response values. There are many versions of OSC 
techniques, which have been discussed in detail and compared [137,138]. 
Du et al. [141] tried to use OSC for removing interfering signals in the first overtone band of 
glucose in blood at 1212–1889 nm. Although they aimed to develop a novel technique, their 
technique is just original OSC using a limited spectral region to estimate the scores and the 
loading weights of the orthogonal components to pretreat the spectra in the other regions. In the 
range 1600–1730 nm, it was found that ROSC-PLS led to an RMSECV of 0.88 mM, while the 
RMSECV values for PLS and OSC-PLS RMSECV were 0.95 mM and 0.95 mM, respectively. 
Digital filtering was also used as a preprocessing step before PLS modeling to remove 
spectral features not associated with glucose [92,93]. For example, Gaussian-shaped bandpass 
digital filters (GSBDF) were implemented using the Fourier filtering technique to reduce both 
high-frequency noise and baseline variations [92]. The measurements of glucose at clinically 
relevant concentrations in a buffered-protein matrix [93] and the measurement in three unique 
undiluted plasma matrices were investigated for a PLS model and a digital filtering-PLS model. 
The authors optimized the number of LVs using a training set by varying the number of LVs 
from 1 to 20 and choosing the one with the lowest SEP. They reported that, in spite of a strong 
overlap between the absorption peaks of glucose and those from the matrix components, such as 
triacetin and protein, a PLS model could be built and predict accurately. By comparing the 
results obtained for PLS and DFF-PLS, the authors reported significant improvements of 53% 
and 70% in SEP for calibration and test sets, respectively. 
Using the NAS technique [101,108,129,132] demonstrated the selectivity of the combination-
band region for quantifying solutes in aqueous solutions. The quality of the spectral signal of the 
solutes and their distinction were determined using an NAS vector. It was found that the models 
based on the combination band resulted in a three-fold lower SEP than those for the first-
overtone band. This was found by NAS, which is the portion of the solute spectrum orthogonal 
to all other sources of spectral variance in the data. The larger the NAS indicates, the greater the 
distinction is [129,132]. Although NAS led to a better result, the model performance was rather 
similar to that of conventional PLS. It was shown that the SEP obtained for glucose was 0.24 
mM using both conventional PLS and NAS [101]. Furthermore, two approaches were used to 
estimate the noise matrix for NAS [108]. The first was by orthogonal projection of calibration 
spectra on the glucose concentration, and the second was by subtracting the contribution of 
glucose from measured spectra. The RMSEP for conventional PLS was 1.08 mM while the 
RMSEPs for NAS were 0.99 mM and 0.88 mM, when the first and second approaches were used 
to define the noise matrix, respectively, indicating that the second approach led to a better 
prediction performance than that of conventional PLS and classical NAS [108].  
 
5. Conclusion, predictions and future directions 
 
Although there has been a lot of research done on different technologies and devices for 
continuous glucose monitoring, so far, none has produced a commercially-available, clinically-
reliable device. Great attention has been given to NIR spectroscopy as a promising technique for 
continuous glucose monitoring. Due to the broad, overlapping absorption peaks in the NIR, MC 
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methods are needed to extract the information on the glucose content from the spectra acquired. 
PLSR was by far the most used technique. As these statistical techniques rely on the calibration 
samples to estimate the relation between NIR spectra and the glucose concentration, they are 
very sensitive to the presence of outliers and unspecific correlations. Proper experimental design 
and model validation are essential to obtain robust calibration models. There have been many 
attempts to develop a CGM system based on NIR spectroscopy, for which promising in-vitro 
results have been reported, but it turned out not to be robust enough for in-vivo use. For many 
other studies, proper validation has not been reported.  
For many properly validated calibration models, the reported SEP values are above 3 mM, 
which, according to the Clarke error grid, is too high to be acceptable for home glucose meters. 
More importantly, it was found that PLS fails when there is unexpected variation. In order to 
overcome this problem, alternative calibration methods have been proposed and shown 
promising results. From the wavelength regions considered in the NIR range, the combination-
band region of 2050–2300 nm has been reported to be the most informative, followed by the 
first-overtone region ranging of 1500–1800 nm. 
In addition, different preprocessing techniques have been applied to build a more robust PLS 
model for glucose measurements. Of all the different preprocessing techniques, it was found that 
those techniques that use expert knowledge to produce PLS calibration models are more robust 
against changes in the interferent levels not covered in the calibration set.  
In conclusion, selection of the most informative variables, proper spectral preprocessing and 
incorporation of expert knowledge in the MC should be considered when building a calibration 
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Fig. 1. Overview of different strategies for blood-glucose monitoring. 
 
Fig. 2. Molar absorptivity spectra of water and glucose in the first overtone (a and b) and combination band (c and 
d) regions, respectively. 
 
Fig. 3. Bias and variance trade-off to prediction error as a function of model complexity (number of Principal 







Table 1.  
Summary overview of case studies discussed in the text 
 
Method  Matrix  Glucose range Wavelengths Ref. 
Univariate 
Calibration  
0.1 M phosphate buffer at pH 7.2  1-20 mM 2273 nm [87] 
 





Bovine serum albumin + 0.1 M 
phosphate buffer (pH 7.2) 



















Plasma 2.5-25.5 mM [93] 
Phosphate buffer at 37°C. Test 
set spectra collected at 
temperatures ranging from 32 to 
41°C with 1°C increments.    
1.25-19.66 mM [88] 
Aqueous solution of a binary 
mixture of glucose and glutamine  
1.66-59.91 mM [94] 
1- Phosphate buffer with five 
unique levels of triacetin.   
2- Phosphate buffer with 10 
different Bovine Serum Albumin 
(BSA) concentrations.  
 
1- 2-20 mM 
2- 1.25- 20 mM 
[99] 
Aqueous solution of Glutamine, 
Ammonia, Lactate and 
Glutamate 
5.5-100 mM [95] 
PLS Human serum 3.1-31.8 mM [100] 
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GA 
1- Triaceton and bovine serum 
albumin (160 samples) 
2- Human serum (238 samples) 
3- Bovine blood (35 samples) 

















1- Methyl isobutyl ketone in 
water (17 samples) 
2- Phosphate buffer with bovine 




3- Human serum [taken from 
126] 
1-20 mM [127] 
GA 
Data sets from ref [126] 1-20 mM [128] 





Phosphate buffer solution with 
lactate and urea. 
1-30 mM For NIR 
2000- 2500 nm  




PLS and NAS 
 
Whole bovine Blood  3-30 mM 1111-1851 nm 
2000-2500 nm 
[132] 
Buffer solution with Lactate, 
Urea, ascorbate triacetin and 
alanine  




Spectra measured through 
different people with diabetes   
- 900-1200 nm [97] 
PLS 
Aqueous solutions at different 
temperatures varying from 25 to 
35 °C 
55-166 mM 1250-1800 nm [89] 
PLS 
ICA and PCA 
Phosphate buffer with urea and 
triacetin  
 
2.7-25 mM 2100-2400 nm [107] 
SCMWPLS 
1- Bovine serum  
 
2-  Forearm of a healthy man   
1- 1.6-83.19 mM 
2- 2.2-10 mM 




For the second 




Buffer matrix with albumin and 
globulin protein   
-  833-2500 nm [130] 
Plasma with protein, cholesterol 
and triglycerides  





1- Aqueous solutions with Na-d-
lactate and urea 
2- Powders of casein and lactate 
1- 1-30 mM 
2-  0-86.9 %  
First data set 
1525 to 1825 
nm  
 





1- Aqueous solutions with Na-d-
lactate and urea 
1- 1-30 mM 
2- 0-86.9 % 
First data set 
1525 to 1825 
[137] 
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Spectra measured through 
Fingers of diabetic type 1 people 
4-16 mM 850-1350 nm [121] 
OSC, ROSC , 
PLS  
 Spectra measured through skin  4.43-9.77 mM 
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